Recent advances in prostate cancer
Read Online
Share

Recent advances in prostate cancer basic science discoveries and clinical advances by Donald Tindall

  • 622 Want to read
  • ·
  • 19 Currently reading

Published by World Scientific Publishing in Singapore .
Written in English

Subjects:

  • Prostate,
  • Cancer,
  • Diagnosis,
  • Treatment

Book details:

Edition Notes

Includes bibliographical references and index.

Statementeditors: Donald J. Tindall, Peter T. Scardino
Classifications
LC ClassificationsRC280.P7 R43 2011
The Physical Object
Paginationxxv, 671 p. :
Number of Pages671
ID Numbers
Open LibraryOL25112853M
ISBN 109814329452
ISBN 109789814329453
LC Control Number2011499696
OCLC/WorldCa755875175

Download Recent advances in prostate cancer

PDF EPUB FB2 MOBI RTF

The treatment of prostate cancer is rapidly progressing on several different fronts, says Celestia Higano, M.D., who discussed several of the latest advances at the Interdisciplinary Prostate Cancer Congress (IPCC). “I want the community to have a sense of the very rapid change of pace of prostate cancer therapy.   Prostate cancer grows so slowly in some men that doctors often recommend active surveillance or watchful waiting instead of more aggressive treatment. recent advances are making it easier to. Advanced Prostate Cancer: Research Update By David Steen Martin New treatments and new combinations of them are giving men with advanced prostate cancer more help than : David Steen Martin. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Moonshot℠ Workshop Highlights Recent Research Advances was originally published by the National Cancer Institute.”.

Robert Ferré's book “Best Prostate Cancer Treatment PROTON BEAM THERAPY” is a seminal work on Prostate Cancer treatment. Robert’s book came to me at a most fortuitous time. I had just been diagnosed with prostate cancer and am now at that juncture where I must commit to a particular prostate cancer : $ prostate cancer,cancer originating in the prostate gland. Prostate cancer is one of the most malignancies in men in the United States, second only to skin cancer, and as a cause of cancer death in men is second only to lung cancer. It occurs predominantly in men 65 years of age and older. Black men have a higher incidence than white men. This book effectively summarizes our knowledge of recent advances in prostate cancer. It focuses on our state-of-the-art understanding of risk factors, prevention, detection, prognosis and treatment of prostate cancer and identifies basic science findings that are being translated into clinical by: 3. Timothy J. Key, in Vegetarian and Plant-Based Diets in Health and Disease Prevention, 13 Prostate Cancer. Little is known about the etiology of prostate cancer, and the only well-established risk factors are increasing age, family history, black ethnic background, and genetic ical studies suggest that risk may be positively associated with a Western-style .

ISBN: OCLC Number: Description: xxv, pages: illustrations ; 23 cm: Contents: Pathology of prostate --Genetic basis for prostate cancer --Androgen receptor converts from a growth suppressor in the normal prostate to an oncogene in prostate cancer --Etiology: role of ETS factor gene fusions --Etiology of prostate cancer: role of .   Prostate adenocarcinomas demonstrate high levels of expression of the transmembrane glycoprotein prostate-specific membrane antigen (PSMA), with lower expression exhibited by other tissues. These features have made it a logical target in the development of new techniques for the diagnosis and treatment of prostate cancer. 1 Many advances in. Recent advances in radiotherapy techniques have already enhanced the accuracy of treatment and should reduce side-effects. Hodgson D, Collins M () Implications of recent advances in radiotherapy techniques and technology For some patients – for example, those with head and neck cancer or prostate cancer – radiotherapy will be.   In , the chemotherapy agent docetaxel was approved for the treatment of metastatic prostate cancer. Although it has taken almost a decade, significant new advances have been made in this area.